医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
ノート
外来がん化学療法部門システムの追加導入と混合調製業務に寄与する因子の多変量解析
池田 賢二竹上 学但馬 重俊宮脇 康至東 真樹子八木 悠理子亀川 秀樹黒川 信夫
著者情報
ジャーナル フリー

2006 年 32 巻 5 号 p. 436-444

詳細
抄録

Pharmaceutical support systems for anti-neoplastic drug preparation for chemotherapy in hospital information systems are in need of improvement. With this in mind we developed a new support system in collaboration with system engineers (SEs) in January 2005. In the presentation of our requirements for the support system to the SEs, the most important part of the development process, we proposed a development model based on an end-user prototype system. The model comprised a five-step design and development of the prototype system through end-user computing, evaluation of the prototype system through actual use, the introduction of a step to determine the exact task requirements, detailed discussions with the SEs, and installation. Among the functions of the prototype system were support functions for the input of prescriptions, inventory management and task data assessment and a print-out function for record sheets. This model produced excellent results for the upgrade whose express purpose was the introduction of an end-user computing step. Furthermore, to evaluate the preparation support system, time-determinative factors involved in the preparation were analyzed and compared using data collected in November 2004 and March 2005. In the evaluation, two pharmacists dispensed a total of 791 and 1003 admixtures for 341 and 426 injection prescriptions, respectively, and the average preparation times were 18.15 and 15.43 minutes/prescription, respectively. Multiple regression analysis revealed several time-determinative factors with correlation coefficients of 0.803 and 0.668. The significant time-determinative factors were the number of vials, ampoules, and bottles for admixtures and the properties of drugs dispensed. The new system has resulted in improved patient safety and operational efficiency.

著者関連情報
© 2006 日本医療薬学会
前の記事 次の記事
feedback
Top